74 related articles for article (PubMed ID: 23492884)
1. Targeted radiotherapy of prostate cancer with a gastrin-releasing peptide receptor antagonist is effective as monotherapy and in combination with rapamycin.
Dumont RA; Tamma M; Braun F; Borkowski S; Reubi JC; Maecke H; Weber WA; Mansi R
J Nucl Med; 2013 May; 54(5):762-9. PubMed ID: 23492884
[TBL] [Abstract][Full Text] [Related]
2. Side-by-side comparison of the two widely studied GRPR radiotracers, radiolabeled NeoB and RM2, in a preclinical setting.
Damiana TST; Paraïso P; de Ridder C; Stuurman D; Seimbille Y; Dalm SU
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3851-3861. PubMed ID: 37584725
[TBL] [Abstract][Full Text] [Related]
3. Radiometal Complexes as Pharmacokinetic Modifiers: A Potent
Schreck MV; Burgard C; Schmidtke A; Hierlmeier I; Stemler T; Maus S; Rosar F; Jung M; Speicher A; Ezziddin S; Holland JP; Bartholomä MD
Mol Pharm; 2023 Dec; 20(12):6463-6473. PubMed ID: 37978936
[TBL] [Abstract][Full Text] [Related]
4. Imaging GRPr Expression in Metastatic Castration-Resistant Prostate Cancer with [
Fernández R; Soza-Ried C; Iagaru A; Stephens A; Müller A; Schieferstein H; Sandoval C; Amaral H; Kramer V
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201600
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Evaluation of Gastrin-Releasing Peptide Receptor Antagonists Labeled with
Holzleitner N; Cwojdzinski T; Beck R; Urtz-Urban N; Hillhouse CC; Grundler PV; van der Meulen NP; Talip Z; Ramaekers S; Van de Voorde M; Ponsard B; Casini A; Günther T
J Nucl Med; 2024 Mar; 65(3):481-484. PubMed ID: 38124121
[TBL] [Abstract][Full Text] [Related]
6. Gastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management: Preclinical and Clinical Developments of the Past 5 Years.
Dalm S; Duan H; Iagaru A
PET Clin; 2024 Jul; 19(3):401-415. PubMed ID: 38644111
[TBL] [Abstract][Full Text] [Related]
7. Towards Cancer Nanoradiopharmaceuticals-Radioisotope Nanocarrier System for Prostate Cancer Theranostics Based on Radiation-Synthesized Polymer Nanogels.
Rurarz BP; Urbanek KA; Karczmarczyk U; Raczkowska J; Habrowska-Górczyńska DE; Kozieł MJ; Kowalska K; Kadłubowski S; Sawicka A; Maurin M; Piastowska-Ciesielska AW; Ulański P
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067350
[TBL] [Abstract][Full Text] [Related]
8. Critical Challenges in Pluvicto Therapy: Incontinent and Anticoagulated Patients.
Crowley JR
J Nucl Med Technol; 2023 Dec; 51(4):279-281. PubMed ID: 37963775
[TBL] [Abstract][Full Text] [Related]
9. Beyond the
Savir-Baruch B; Parent E
AJR Am J Roentgenol; 2024 May; ():. PubMed ID: 38748727
[No Abstract] [Full Text] [Related]
10. Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.
Nock BA; Kaloudi A; Lymperis E; Giarika A; Kulkarni HR; Klette I; Singh A; Krenning EP; de Jong M; Maina T; Baum RP
J Nucl Med; 2017 Jan; 58(1):75-80. PubMed ID: 27493272
[TBL] [Abstract][Full Text] [Related]
11. Characterization and evaluation of DOTA-conjugated Bombesin/RGD-antagonists for prostate cancer tumor imaging and therapy.
Stott Reynolds TJ; Schehr R; Liu D; Xu J; Miao Y; Hoffman TJ; Rold TL; Lewis MR; Smith CJ
Nucl Med Biol; 2015 Feb; 42(2):99-108. PubMed ID: 25459113
[TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of a bispecific low-molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer.
Eder M; Schäfer M; Bauder-Wüst U; Haberkorn U; Eisenhut M; Kopka K
Prostate; 2014 May; 74(6):659-68. PubMed ID: 24464532
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.
Afshar-Oromieh A; Avtzi E; Giesel FL; Holland-Letz T; Linhart HG; Eder M; Eisenhut M; Boxler S; Hadaschik BA; Kratochwil C; Weichert W; Kopka K; Debus J; Haberkorn U
Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):197-209. PubMed ID: 25411132
[TBL] [Abstract][Full Text] [Related]
14. N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging.
Gourni E; Mansi R; Jamous M; Waser B; Smerling C; Burian A; Buchegger F; Reubi JC; Maecke HR
J Nucl Med; 2014 Oct; 55(10):1719-25. PubMed ID: 25146125
[TBL] [Abstract][Full Text] [Related]
15. First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [
Kurth J; Krause BJ; Schwarzenböck SM; Bergner C; Hakenberg OW; Heuschkel M
Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):123-135. PubMed ID: 31482426
[TBL] [Abstract][Full Text] [Related]
16. 68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology.
Dalm SU; Bakker IL; de Blois E; Doeswijk GN; Konijnenberg MW; Orlandi F; Barbato D; Tedesco M; Maina T; Nock BA; de Jong M
J Nucl Med; 2017 Feb; 58(2):293-299. PubMed ID: 27609789
[TBL] [Abstract][Full Text] [Related]
17. Pilot Comparison of ⁶⁸Ga-RM2 PET and ⁶⁸Ga-PSMA-11 PET in Patients with Biochemically Recurrent Prostate Cancer.
Minamimoto R; Hancock S; Schneider B; Chin FT; Jamali M; Loening A; Vasanawala S; Gambhir SS; Iagaru A
J Nucl Med; 2016 Apr; 57(4):557-62. PubMed ID: 26659347
[TBL] [Abstract][Full Text] [Related]
18. Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer.
Zhang H; Qi L; Cai Y; Gao X
Ann Med; 2024 Dec; 56(1):2320301. PubMed ID: 38442298
[No Abstract] [Full Text] [Related]
19. Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology.
Kanellopoulos P; Mattsson A; Abouzayed A; Obeid K; Nock BA; Tolmachev V; Maina T; Orlova A
EJNMMI Radiopharm Chem; 2024 Feb; 9(1):13. PubMed ID: 38366299
[TBL] [Abstract][Full Text] [Related]
20. The Balance Between the Therapeutic Efficacy and Safety of [
Verhoeven M; Haeck J; de Blois E; Orlandi F; Barbato D; Tedesco M; Konijnenberg M; Dalm SU
Mol Imaging Biol; 2024 Feb; 26(1):114-123. PubMed ID: 37640941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
